The recent clinical trial sponsored by the Ramon y Cajal University Hospital’s Foundation for Biomedical Investigation, and in collaboration with GW Pharmaceuticals (makers of the cannabis formulation Sativex ), was the first ever to use cannabis in patients with Huntington’s Disease.

It just to happens that the endocannabinoid system is intricately tied to the progression of Huntington’s Disease.

A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

@HIGH_TIMES_Mag: “First Clinical Trial With Cannabis for #Huntingtons Disease Shows Promising Results”
Researchers from the Ramon y Cajal University Hospital’s Foundation for Biomedical Investigation in Madrid have recently completed the first ever clinical trial to investigate a cannabis extract as a treatment for Huntington’s Disease.
First Clinical Trial With Cannabis for Huntington’s Disease Shows Promising Results